EXELA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EXELA PHARMA, and when can generic versions of EXELA PHARMA drugs launch?
EXELA PHARMA has twenty-three approved drugs.
There are sixteen US patents protecting EXELA PHARMA drugs.
Summary for EXELA PHARMA
| US Patents: | 16 |
| Tradenames: | 20 |
| Ingredients: | 20 |
| NDAs: | 23 |
| Patent Litigation for EXELA PHARMA: | See patent lawsuits for EXELA PHARMA |
Drugs and US Patents for EXELA PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 11,826,383 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 10,583,155 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Exela Pharma | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-001 | Jun 27, 2014 | AP1 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Exela Pharma | GLYRX-PF | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210997-004 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Exela Pharma | POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 206203-001 | Dec 29, 2015 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 11,648,262 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 10,905,713 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
